![Matthew Wiley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Wiley
Corporate Officer/Principal chez
DEFINIUM THERAPEUTICS, INC.
Fortune : 14 M $ au 31/08/2026
Profil
Matthew T.
Wiley is Chief Commercial Officer at Definium Therapeutics, Inc. since 2025.
Former roles include Chief Commercial Officer & Senior Vice President at BioXcel Therapeutics, Inc. from 2022 to 2024; Chief Commercial Officer at VYNE Pharmaceuticals Ltd. from 2018 to 2020; Vice President-Marketing at Jazz Pharmaceuticals, Inc. from 2012 to 2018; Vice President-Marketing at Jazz Pharmaceuticals Commercial Corp.
from 2007 to 2012; and Chief Commercial Officer at Menlo Therapeutics, Inc. Education includes undergraduate studies at Syracuse University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 25/09/2026 | 359 036 ( 0,27% ) | 14 M $ | 31/08/2026 |
Postes actifs de Matthew Wiley
| Sociétés | Poste | Début |
|---|---|---|
| DEFINIUM THERAPEUTICS, INC. | Corporate Officer/Principal | 17/03/2025 |
Anciens postes connus de Matthew Wiley
| Sociétés | Poste | Fin |
|---|---|---|
| BIOXCEL THERAPEUTICS, INC. | Corporate Officer/Principal | 02/10/2024 |
VYNE Pharmaceuticals Ltd.
 VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for dermatology, gynecology, wounds and burns and ophthalmic disorders | Corporate Officer/Principal | 09/03/2020 |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Sales & Marketing | 01/01/2018 |
Jazz Pharmaceuticals Commercial Corp.
 Jazz Pharmaceuticals Commercial Corp. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical services | Sales & Marketing | 01/01/2012 |
Jazz Pharmaceuticals Commercial Corp.
Jazz Pharmaceuticals Commercial Corp. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical services | Sales & Marketing | - |
Formation de Matthew Wiley
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
62
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
VYNE Pharmaceuticals Ltd.
VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for dermatology, gynecology, wounds and burns and ophthalmic disorders | Health Technology |
Menlo Therapeutics, Inc.
 Menlo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of serlopitant products | Health Technology |
Syracuse University
 Syracuse University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jazz Pharmaceuticals Commercial Corp.
Jazz Pharmaceuticals Commercial Corp. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical services | Health Technology |
BioXcel Therapeutics, Inc.
 BioXcel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops transformative medicines in neuroscience and immuno-oncology | Health Technology |
Mind Medicine (MindMed), Inc.
 Mind Medicine (MindMed), Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical biopharmaceutical company which develops novel products to treat brain health disorders | Health Technology |
VYNE Therapeutics, Inc.
 VYNE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
